Alkermes PLC logo

Alkermes PLC

ALKS
Healthcare|Drug Manufacturers - Specialty & Generic|Ireland
$51.95
-1.82 (-3.39%)
DCF (FCF)
$20.11
Earnings Power
$12.19

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 1811.28, 1879.29, 2072.58, 2334.36, 2636.26 ], "ebit_estimate": [ 12.51, 208.62, 380.71, 672.25, 962.25 ], "ebitda_estimate": [ 399.41, 390.68, 548.75, 802.72, 1023.09 ], "net_income_estimate": [ -65.62, 75.37, 297.05, 532.75, 779.36 ], "per_share_eps_estimate": [ -0.27, 0.52, 1.74, 3, 4.43 ], "eps_nri_estimate": [ -0.39, 0.39, 1.73, 3.05, 4.43 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 11.06, 12.53, 14.71, 15.92, null ], "pretax_income_estimate": [ -62.44, 115.55, 369.64, 633.08, 946.4 ], "operating_cash_flow_per_share_estimate": [ 2.58, 1.95, 2.52, 2.57, null ], "roa_estimate": [ -2.2, 0.3, 2.1, 5.5, null ], "roe_estimate": [ -2.86, 8.4, 12.23, 9.5, null ], "gross_margin_estimate": [ 81.69, 87.23, 87.29, 88.2, 88.13 ], "operating_cash_flow_estimate": [ 428.79, 323.53, 417.98, 427.12, null ], "pettm_estimate": [ 0, 100.68, 29.91, 17.34, 11.72 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "11.13", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 11.13, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": 10.21, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": 10.52, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 457.82, 472.47, 488.11, 445.7, 461.08, 460.85, 468.05 ], "ebit_estimate": [ 18.52, 22.87, 19.85, -5.71, 12.51, 6.49, 11.43 ], "ebitda_estimate": [ 106.64, 107.47, 102.35, null, null, null, null ], "net_income_estimate": [ -3.37, 1.24, 2.85, -25.28, -7.36, -12.3, -6.82 ], "per_share_eps_estimate": [ 0.01, 0.03, 0.04, -0.15, -0.05, -0.08, -0.04 ], "eps_nri_estimate": [ -0.02, 0, 0.02, -0.15, -0.05, -0.08, -0.04 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -3.21, 2.51, -0.33, -26.41, -7.39, -12.52, -6.93 ], "operating_cash_flow_per_share_estimate": [ 2.47, 2.48, 2.7, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ 80.41, 80.7, 81.75, 84.7, 85.3, 85.3, 85.3 ], "operating_cash_flow_estimate": [ 410.5, 412.17, 448.73, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "11.13", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": 11.13, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": 10.21, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": 10.52, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

News

2026-07-10 21:30:49
2026-07-07 00:00:21
2026-07-02 12:17:13
2026-06-29 23:07:05
2026-06-29 14:05:57
2026-06-29 12:32:38
2026-06-24 11:33:13
2026-06-24 01:00:00
2026-06-22 16:36:02
2026-06-18 10:52:22
2026-06-18 10:31:18
2026-06-17 21:58:58
2026-06-17 21:00:10
2026-06-17 20:54:27
2026-06-15 12:00:11
2026-06-13 02:00:30